-
A Beacon of Hope: Cancer BiomarkersSharon and her daughter’s story underscores the potential of comprehensive genomic profiling to help inform cancer treatment decisions.
sponsored by Eli Lilly and Company
Despite receiving uniquely intensive therapies, people with blood cancers are less likely to receive palliative care than those with solid tumors.
by Cameron Walker
-
Can Steroids Impair Immunotherapy for Cancer?A new study suggests steroids could blunt the effects of some immunotherapies, but researchers say they remain necessary for some patients.
by Kyle Bagenstose -
Treatment Combination Improves Survival in Platinum-resistant Ovarian CancerPreliminary results found that combining relacorilant with nab-paclitaxel improved outcomes for women with advanced ovarian cancer.
by Sandra Gordon -
CAR T-cell Therapy Shows Response in Rare Brain CancerPotential new approach to treating diffuse intrinsic pontine glioma uses engineered immune cells infused directly to the brain.
by Taneia Surles -
Technology’s Changing Role in Cancer CareExperts explain how artificial intelligence, nanotechnology and decentralized care are poised to improve research, detection and treatment.
by Thomas Celona -
Immunotherapy for Early-stage Gastric Cancer‘Practice-changing’ research shows adding immunotherapy before and after surgery reduced recurrences for early-stage gastric cancer.
by Laura Gesualdi Gilmore
Support for Cancer Today has been provided in part by an independent educational grant from Merck & Co., Inc.
All editorial content is produced independently by the Cancer Today editorial team.
-
Pediatric Cancer’s AftershocksNew research highlights approaches that could provide better long-term quality of life for childhood cancer survivors.
-
What Are the Benefits of Exercise for Cancer Patients?Several recent studies have explored how exercise can impact a cancer patient’s survival, risk of recurrence, and overall quality of life.
Cancer Research at a Crossroads
The AACR Cancer Progress Report, which is published annually by the American Association for Cancer Research, tracks recent developments that impact cancer care. Click “Progress Report” below to find out more.
Support for Cancer Today has been provided in part by an independent educational grant from Merck & Co., Inc.
All editorial content is produced independently by the Cancer Today editorial team.
